BIIB: Biogen Company Cash Volume

Symbol and logo of brand Biogen Inc (BIIB)

The cash balance from the GURU.Markets terminal is illustrated by this chart, where the indicator remains around 1.30, confirming margin stability during the drug portfolio transition. Biogen Inc. (BIIB) leverages its vast experience in brain therapy to fund the search for breakthrough solutions. Expansion into the SMA and Alzheimer's disease segments defines the growth potential for Biogen Inc. (BIIB) in the global market.

BIIB - Biogen Inc Company Liquid Assets over the range 07/04/2022 - 11/21/2026

Biogen (BIIB) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
Analysis of all company metrics:Biogen Idec BIIB
Signature product of biogen.com

For Biogen Inc. (BIIB), the volume of liquid assets is a critical resource as the company shifts its market focus from sclerosis medications to innovations in Alzheimer's disease therapy. This cash balance trend captures the total amount of cash and equivalents, allowing for a real-time assessment of actual solvency. The growth of this metric confirms a financial reserve for expansion into new markets; however, excessive stagnation of funds signals issues regarding capital allocation efficiency.

Analysis of competing companies

Company Cash Volume NBIX|RGC - Company Cash Reserve|Company Cash Funds Axsome Therapeutics AXSM|Company Cash Volume ACADIA Pharmaceuticals Inc. ACAD|xenon-pharma.com - Company Cash Volume|Company Cash Reserve Viking Therapeutics|SUPN: Company Cash Volume|Catalyst Pharmaceuticals (CPRX) - Company Cash Volume|Company Cash on Hand DNLI|Company Cash and Cash Equivalents HRMY (Harmony Biosciences Holdings, Inc.)|Company Cash Funds Biohaven Ltd. (BHVN)|Company Total Cash Amount AMLX|Company Cash Funds trevitherapeutics.com TRVI|PRAX - Company Cash on Hand|Anavex Life Sciences Corp - Company Cash Volume|Company Cash Reserve CeriBell Corp|Prothena Corporation PLC (PRTA) - Company Cash Funds|Alector Therapeutics - Company Cash Balance|Company Cash Funds Annexon Biosciences|Company Cash Reserve omeros.com OMER|Company Cash Funds Neurogene (NGNE)|Company Liquid Assets AC Immune S.A.|Company Cash Volume VYGR (Voyager Therapeutics Inc)|Company Cash Balance NMRA|scilexholding.com - Company Cash Volume|TVGN (tevogen.com) - Company Cash and Cash Equivalents|ACOG: Company Cash Volume|CGTX: Company Total Cash Amount|Company Cash Funds Inhibikase Therapeutics|Company Cash and Cash Equivalents SAVA (Cassava)|Company Cash Funds Assertio Therapeutics (ASRT)|Coya Therapeutics - Company Cash and Cash Equivalents|VistaGen Therapeutics, Inc. - Company Cash on Hand|ovidrx.com (OVID) - Company Cash Reserve|ABOS: Company Cash on Hand|Company Cash Reserve CervoMed Inc|alteritytherapeutics.com (ATHE) - Company Cash Funds|Company Cash on Hand Clene Nanomedicine|Company Cash on Hand PEPG|Company Cash Reserve Jupiter Neurosciences JUNS|Company Cash Funds Relmada (RLMD)|Company Liquid Assets Annovis Bio, Inc.|Company Cash Volume GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Company Cash Reserve|KLTO - Company Cash Funds|Company Cash Reserve NeuroSense Therapeutics Ltd|RVPH: Company Cash Volume|MetaVia, Inc. (MTVA) - Company Cash Volume|Company Cash Funds NeurAxis|Company Cash Volume heliusmedical.com|Company Cash on Hand PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Company Cash and Cash Equivalents|Minerva Neurosciences Corp - Company Cash on Hand|Company Cash Balance ATHA|ADXN - Company Cash Funds|Company Cash Reserve Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Company Cash Funds|Company Cash and Cash Equivalents PTIX|KTTA (pasitheaclinics.com) - Company Cash Volume|CRGT (cortigent.com) - Company Total Cash Amount|Company Cash Volume ATXI|Company Cash Funds BCLI (Brainstorm Cell)|Company Cash Volume CARA (Cara Therapeutics Inc)|Company Cash Balance CHRO|Eliem Therapeutics Inc. - Company Cash Volume|ITCI - Company Cash Volume|Longboard Pharma (LBPH) - Company Cash Funds|Company Cash on Hand Marinus Pharmaceuticals|Company Cash Funds NKGen|Company Cash Volume NeuroBo Pharmaceuticals, Inc.|Company Cash Volume SAGE|Synaptogenix, Inc - Company Cash and Cash Equivalents|Company Cash Funds Trevena TRVN|Company Cash Position Vigil Neuroscience|Anew Medical Inc. - Company Cash Volume|Company Liquid Assets Cerevel Therapeutics, Inc. CERE